Cambridge Healthtech Institute’s Inaugural

Immunotherapy for COVID-19

Vaccine and Biotherapeutic Development for SARS-CoV-2

October 8, 2020

In response to the urgent need for vaccines and biotherapeutics for the novel coronavirus, Cambridge Healthtech Institute is adding a new track dedicated to COVID-19 to our Immuno-Oncology Summit that aims to facilitate innovation and collaboration in immunotherapy approaches to control the cytokine storm, develop novel antibody biotherapeutics and vaccines, and understand the immune response mechanisms.

Connect With Us


For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute


For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286


For media and association partnerships, please contact:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.972.5415